kanamycin a has been researched along with guaifenesin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hayashi, H | 1 |
| Bergogne-Berezin, E; Dupuy, L; Langeard, MM; Morel, C; Vergnaud, M | 1 |
| DUMON, G; DUMON-LEGRE, M | 1 |
| DUMON, G | 1 |
1 review(s) available for kanamycin a and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for kanamycin a and guaifenesin
| Article | Year |
|---|---|
[Inhibitory effect of nasal mucus on the absorption of drugs through respiratory epithelium].
Topics: Absorption; Animals; Chronic Disease; Dibekacin; Epithelium; Humans; In Vitro Techniques; Kanamycin; Mucus; Nasal Mucosa; Rabbits; Sinusitis; Trachea | 1990 |
[Dibekacin: diffusion in bronchial mucus].
Topics: Adult; Aged; Bronchi; Dibekacin; Humans; Kanamycin; Kinetics; Middle Aged; Mucus; Respiratory Tract Infections | 1982 |
[Kanamycin, aerosols and pulmonary tuberculosis. Treatment of pulmonary tuberculosis with aerosols of kanamycin combined with diffusion factors].
Topics: Aerosols; Anti-Bacterial Agents; Kanamycin; Mucus; Tuberculosis; Tuberculosis, Pulmonary | 1961 |
[Trial therapy of pulmonary tuberculosis with aerosols of kanamycin combined with diffusion factors].
Topics: Aerosols; Anti-Bacterial Agents; Kanamycin; Mucus; Tuberculosis; Tuberculosis, Pulmonary | 1961 |